摘要
替罗非班是一种可逆性糖蛋白Ⅱb/Ⅲa受体拮抗剂,具有抑制血小板聚集、延长出血时间、减少血栓形成等作用,但其具有潜在的致血小板减少及出血风险。本文报道了1例经皮冠状动脉介入术(PCI)后应用替罗非班所致极重度血小板减少症患者,以提高临床医生对替罗非班致极重度血小板减少症的认识。
Tirofiban is one of reversible receptor antagonist of glycoprotein GP Ⅱ b/Ⅲ a, can inhibit the aggregation of platelets, lengthen the bleeding time and reduce the thrombosis, but may cause thrombocytopenia and hemorrhage. This paper reported one patient with tirofiban-induced extremely severe thrombocytopenia after PCI, to improve the recognition of clinicians.
作者
李明珠
徐良成
张勇
LI Ming-zhu;XU Liang-cheng;ZHANG Yong(The First People＇ s Hospital of Lianyungang, Lianyungang 222002, Chin)
出处
《实用心脑肺血管病杂志》
2018年第3期119-120,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
